Cargando…

Survivin’ Acute Myeloid Leukaemia—A Personalised Target for inv(16) Patients

Despite recent advances in therapies including immunotherapy, patients with acute myeloid leukaemia (AML) still experience relatively poor survival rates. The Inhibition of Apoptosis (IAP) family member, survivin, also known by its gene and protein name, Baculoviral IAP Repeat Containing 5 (BIRC5),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greiner, Jochen, Brown, Elliott, Bullinger, Lars, Hills, Robert K., Morris, Vanessa, Döhner, Hartmut, Mills, Ken I., Guinn, Barbara-ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508831/ https://www.ncbi.nlm.nih.gov/pubmed/34638823 http://dx.doi.org/10.3390/ijms221910482

Ejemplares similares

Molecular Mechanisms and Therapies of Myeloid Leukaemia
por: Brown, Elliott, et al.
Publicado: (2022)

Faggot cells in therapy‐related acute myeloid leukemia with inv(16)
por: Vega González de Viñaspre, Ana, et al.
Publicado: (2020)

Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)

Genome-wide binding of transcription factors in inv(16) acute myeloid leukemia
por: Mandoli, A., et al.
Publicado: (2014)

The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia
por: Kim, Hyung-Gyoon, et al.
Publicado: (2017)

Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia
por: Pulikkan, John Anto, et al.
Publicado: (2018)

A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemia
por: Korfi, K., et al.
Publicado: (2015)

Identification of Genes Whose Expression Overlaps Age Boundaries and Correlates with Risk Groups in Paediatric and Adult Acute Myeloid Leukaemia
por: Davis, Lindsay, et al.
Publicado: (2020)

microRNA expression in acute myeloid leukaemia: New targets for therapy?
por: Fletcher, Daniel, et al.
Publicado: (2022)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia
por: Guinn, Barbara-ann, et al.
Publicado: (2007)

A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis
por: Morris, Vanessa S., et al.
Publicado: (2023)

Constitutional pericentric inversion of chromosome 16, inv(16)(p13.1q22), mimicking acute myeloid leukemia
por: Ozaki, Shuji, et al.
Publicado: (2022)

PB1836: LOSS OF HETEROZYGOSITY IN AML PATIENTS WITH INV(16)
por: Bessmertniy, Dmitry, et al.
Publicado: (2023)

Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model
por: Connell, Barry J., et al.
Publicado: (2012)

Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance
por: Zhang, Lianjun, et al.
Publicado: (2021)

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
por: Young, Christine S., et al.
Publicado: (2015)

Inv(3) Acute Myeloid Leukemia in a Young Adult and Review of the Literature
por: Blakemore, Carlee, et al.
Publicado: (2023)

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
por: Han, Eunhee, et al.
Publicado: (2014)

Acute Myeloid Leukemia With Inv(16)(p13q22) Associated With Hidden Systemic Mastocytosis: Case Report and Review of Literature
por: Hilmi, Feryal Abbas Ibrahim, et al.
Publicado: (2017)

Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers
por: Lueck, Sonja C., et al.
Publicado: (2016)

Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
por: Zhai, Yanan, et al.
Publicado: (2022)

H->inv at ATLAS+CMS
por: Albert, Andreas
Publicado: (2021)

A rare case of isolated myeloid sarcoma of the small gut with inv(16)(p13;q22) without bone marrow involvement
por: Mandal, Prakas Kumar, et al.
Publicado: (2014)

A Case of Acute Myeloid Leukemia With inv(16)(p13.1q22);CBFB-MYH11 Presenting With Faggot Cells
por: Kim, Jung-Ah, et al.
Publicado: (2021)

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia
por: Cairns, Lauren V., et al.
Publicado: (2021)

OsINV3 and Its Homolog, OsINV2, Control Grain Size in Rice
por: Deng, Xiaoshu, et al.
Publicado: (2020)

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
por: Hirsch, Susanne, et al.
Publicado: (2017)

Construction and detection of the tissue-specific pINV-HPV16 E6/7 vector
por: GAO, HUI, et al.
Publicado: (2015)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
por: Boullosa, Laurie Freire, et al.
Publicado: (2017)

Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
por: Dutta, Sayantanee, et al.
Publicado: (2020)

Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate
por: Arahata, Masahisa, et al.
Publicado: (2015)

The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities
por: Chilton, L, et al.
Publicado: (2016)

Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised Medicine
por: Galán-Gómez, Víctor, et al.
Publicado: (2022)

VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice
por: Gentner, Eva, et al.
Publicado: (2016)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

The EHA Research Roadmap: Malignant Myeloid Diseases
por: Döhner, Hartmut, et al.
Publicado: (2021)

Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
por: Meyer, Tatjana, et al.
Publicado: (2019)

GM AND INV FACTORS IN SUBCLASSES OF HUMAN IGG
por: Terry, William D., et al.
Publicado: (1965)

Cannot write session to /tmp/vufind_sessions/sess_772m8k43tqmqg0s25k71ub0297